Formulary

FDA Update: Report Claims “Power Grab,” Dems Say Hahn Blocked From Testifying

September 20, 2020

Reports say Azar is asserting control over FDA as vaccine trials near completion, while Hahn is blocked from testifying on COVID-19.

The Challenges of Treating Primary Progressive MS

September 13, 2020

A session at MSVirtual2020 covers the difficulty of finding treatments for some forms of MS.

5 Takeaways From the European Society of Cardiology 2020 Congress

September 02, 2020

The 2020 meeting, presented in a virtual format from its original host city of Amsterdam, The Netherlands, had lots of important science and a record number of viewers.

Electronic Prior Authorization is Catching on

August 27, 2020

But there are plenty of holdouts. Half of submissions are still done by phone or fax.

ViiV Healthcare Receives FDA Approval for Drug to Treat Adults with HIV-1

August 08, 2020

Dovato lets adults with HIV reduce the number of antiretroviral therapies they take, while maintaining efficacy and a high barrier to resistance comparable to tenofovir-based regimens.

An Update for Cardiologists Who See Patients With Type 2 Diabetes

August 05, 2020

The American College of Cardiology issues its second set of recommendations for its members on prescribing two groups of drugs first developed for type 2 diabetes.

5 Tips for Employers on Reforming and Optimizing Medication Use

August 04, 2020

Lives can be saved, physician burnout and waste can be reduced, and drug costs can decrease by achieving medication optimization through comprehensive medication management.

Is the Biosimilars Waiting Game Finally Over?

July 30, 2020

Advocates say a number of regulatory changes could help bring more of these products on to the market.

FDA Updates: Brilinta’s Priority Review in Stroke; Biogen’s Alzheimer’s BLA; Mytesi IND in Cancer Care

July 11, 2020

Drug development in key areas of unmet need hit milestones this week, with Biogen, AstraZeneca, and Jaguar Health announcing regulatory steps with the FDA.

Word From FDA, NIH on COVID-19 Vaccine: No Cutting Corners

July 05, 2020

FDA outlines what it will take to get a COVID-19 vaccine approved, while NIH offers its research strategy.

Keytruda Approved for Early Treatment of Colorectal Cancer in Patients With Genetic Mutations

June 30, 2020

FDA approves Merck's Keytruda for certain patients with metastatic colorectal cancer a month after study results were presented at ASCO.

5 Developments Changing the CAR-T Landscape

June 28, 2020

An off-the-shelf version of CAR-T therapy that uses the immune system’s natural killer cells is a possibility. But the high price of CAR-T shows some doubts about how widely it can be used.

Out-of-Pocket Costs for Diabetes Medicine Eliminated

January 31, 2020

New plan from CVS Caremark eliminates member cost as a barrier to medications without raising costs for benefits, premiums or deductibles.

Top Issues Facing Pharma in 2020

January 11, 2020

Novel drugs, value-based contracting, biosimilars, and regulatory activity addressing costs will be among the hot button issues in the coming year.

Will Outcomes-Based Payments Hit COPD Drugs?

November 29, 2018

In these arrangements, drug companies must partially reimburse insurers if the drug fails to earn its keep. Will COPD drugs be included in such arrangements?

Will Drug Price Hikes Impact Drug Spending?

November 28, 2018

Despite a scolding from President Trump over drug price hikes, drug giant Pfizer announced it will raise the prices of 41 medications in January. That’s 10% of its entire drug portfolio.

‘Encouraging’ COPD drug pipeline could ease symptoms, address root causes

November 07, 2017

Albert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow and address the underlying disease process.